Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Takeda Pharmaceutical (TKPHF) Income from Non-Controlling Interests (2017 - 2025)

Historic Income from Non-Controlling Interests for Takeda Pharmaceutical (TKPHF) over the last 9 years, with Q4 2025 value amounting to $7.5 million.

  • Takeda Pharmaceutical's Income from Non-Controlling Interests rose 123288.47% to $7.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.5 million, marking a year-over-year increase of 59381.52%. This contributed to the annual value of $5.9 million for FY2025, which is 55179.8% up from last year.
  • As of Q4 2025, Takeda Pharmaceutical's Income from Non-Controlling Interests stood at $7.5 million, which was up 123288.47% from -$1.4 million recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Income from Non-Controlling Interests registered a high of $7.5 million during Q4 2025, and its lowest value of -$1.4 million during Q3 2025.
  • In the last 5 years, Takeda Pharmaceutical's Income from Non-Controlling Interests had a median value of $80266.1 in 2023 and averaged $286349.0.
  • Within the past 5 years, the most significant YoY rise in Takeda Pharmaceutical's Income from Non-Controlling Interests was 123288.47% (2025), while the steepest drop was 50473.67% (2025).
  • Over the past 5 years, Takeda Pharmaceutical's Income from Non-Controlling Interests (Quarter) stood at $448660.1 in 2021, then crashed by 65.29% to $155723.0 in 2022, then plummeted by 48.46% to $80266.1 in 2023, then plummeted by 919.5% to -$657777.4 in 2024, then surged by 1232.88% to $7.5 million in 2025.
  • Its Income from Non-Controlling Interests stands at $7.5 million for Q4 2025, versus -$1.4 million for Q3 2025 and -$691110.6 for Q2 2025.